EquityZen Review: Morgan Stanley Ownership, 2.5% Fees and Pre-IPO Access

This section establishes what EquityZen is as a legal matter, who built it, who owns it, and how big it is. The one-sentence answer: EquityZen is a broker-dealer-affiliated marketplace that forms a fund for each block of private shares an employee wants to sell, then sells units of that fund to accredited investors and takes a placement fee from both sides.

The entities

The operating company is EquityZen Inc., founded in New York in 2013 by Atish Davda (chief executive) and Phil Haslett (co-founder and chief strategy officer), with Shriram Bhashyam as a third co-founder (Wikipedia, retrieved September 2026; unverified at publication). Its regulated arm is EquityZen Securities LLC, registered with the SEC as a broker-dealer since May 11, 2016 (SEC file 8-69689) and a FINRA member under CRD number 281820 (FINRA BrokerCheck, retrieved September 2026). The broker-dealer earns the placement fee; every EquityZen fund’s Form D names it as the recipient of sales compensation (SEC Form D, EquityZen Growth Technology Fund LLC Series 2294, June 16, 2026).

The funds themselves sit under a Delaware series LLC called EquityZen Growth Technology Fund LLC. Each block of shares becomes a numbered series with its own Form D. The series numbers tell you the scale: Series 2033 filed its Form D in December 2024 (EDGAR; unverified at publication) and Series 2294 on June 16, 2026, roughly 260 new single-company funds in 18 months. The Series 2294 filing is a useful specimen: $180,832 raised from 15 investors under Rule 506(b), first sale June 15, 2026, Phil Haslett signing as representative of the fund’s manager, and a commission line of $4,520 to EquityZen Securities, which is 2.5% to the dollar (SEC Form D, June 16, 2026; commission line unverified at publication). Older series on EDGAR range from about $100,000 to $480,000 raised, so the typical EquityZen fund is small: a dozen or two investors sharing one employee’s block.

A separate family of actively managed multi-company funds, as of September 2026 the EquityZen Growth Opportunity Fund XI LLC and Fund XII LLC, pools investors across 15 or more companies and charges a management fee and carried interest (EquityZen help center, “Investing in Growth Opportunity Fund XI LLC”, retrieved September 2026).

The owner

On October 29, 2025 Morgan Stanley announced an agreement to buy EquityZen, the first acquisition under chief executive Ted Pick; the price was not disclosed (Morgan Stanley press release, October 29, 2025; Bloomberg, October 29, 2025; WilmerHale, October 29, 2025). The deal closed on January 27, 2026 (Morgan Stanley press release, January 27, 2026). EquityZen sits inside Morgan Stanley Wealth Management, whose head, Jed Finn, framed the purchase as a way to “seamlessly connect supply and demand at scale” between Morgan Stanley at Work, the unit that runs equity plans for private companies, and the bank’s wealth clients (same release).

Before the sale EquityZen was unusually lightly funded for a fintech. Davda told Axios on November 4, 2025 that the company had raised a total of $7M and funded its own operations for almost ten years (Axios, November 4, 2025). It had been a 110-person company before it cut 27% of staff in October 2022 as accredited-investor demand for startup stock collapsed (Axios, October 31, 2022). We could not find a public statement of either founder’s title inside Morgan Stanley; Haslett was still signing Form Ds in June 2026.

How big it is

Every volume figure here is the platform’s own. Morgan Stanley said EquityZen had more than 800,000 registered users and had processed more than 49,000 transactions across more than 450 private companies since 2013 (Morgan Stanley press releases, October 29, 2025 and January 27, 2026). EquityZen’s own 2025 year in review reported a 100% increase in transactions year over year, a rise of more than 200% in first-time investors, and 16 portfolio-company exits in the year including Circle, CoreWeave and Klarna (EquityZen blog, “2025 Private Markets Year in Review”, December 2025). None gives dollar volume; neither EquityZen nor Morgan Stanley has published one. Registered users is a sign-up count, not a funded-account count, and the 49,000 transactions include the seller side and the Express Deal resales.

This section walks the money from sign-up to exit and shows where EquityZen is paid at each step. Most of the complaints, and most of the risk, live in the eight to eleven weeks between your wire and the fund’s close.

Eligibility and onboarding

You must be an accredited investor under Regulation D: $200,000 of individual income ($300,000 with a spouse) in each of the last two years, or $1M of net worth excluding your primary residence (EquityZen help center, “Accredited investor information”, retrieved September 2026). EquityZen sells under Rule 506(b), which lets it accept your own certification of accredited status rather than the third-party verification Rule 506(c) would require (Form D, Series 2294, June 16, 2026). Sign-up is free. Self-directed IRAs are accepted mainly through Alto IRA; EquityZen says it does not accept every custodian (EquityZen help center, “Can I invest with a self-directed IRA?”, retrieved September 2026; unverified at publication).

Sourcing and pricing

Supply comes from employees and early investors who want cash before an IPO. A seller submits a sales inquiry with the company, share count and asking price; EquityZen reviews the company’s transfer restrictions and, where the company has a right of first refusal (ROFR), works with the company on the process (EquityZen help center, “Right of First Refusal (ROFR) clause”, retrieved September 2026). The price on a listing is set by the seller against the market EquityZen sees. Buyers can also submit a Bid, a binding price and size shown to the seller; if the seller accepts, EquityZen generates the transaction documents on those terms and you are committed (EquityZen help center, “EquityZen Bids: FAQ Guide”, retrieved September 2026).

What you own

On a Standard Deal you do not buy shares. You buy membership units in a numbered series of EquityZen Growth Technology Fund LLC, and that series buys the shares from the seller (EquityZen help center, “Types of deals on EquityZen”; Form D filings). The fund holds the stock; you hold a pro rata claim on the fund. Linqto used the same fund-of-one structure, and its customers learned in 2025 that many of them never owned the securities they thought they did (see the risks section). EquityZen’s version has two features Linqto’s lacked in practice: a FINRA-member broker-dealer in the chain of every sale, and a Form D on EDGAR for every series, the closest thing to a public record that a specific fund exists.

There are three other formats. Direct Share Acquisitions let a large buyer take shares onto their own name rather than through a fund, with a 2.5% fee on the first $10M and 2% above (EquityZen help center, “Direct Share Acquisitions (DSA)”). Express Deals are resales of existing fund units from one EquityZen investor to another, which need no company approval and can close in as little as three days (EquityZen help center, “Express Deals”). Managed funds, the Growth Opportunity series, are diversified vehicles run by an EquityZen investment committee with a five- to seven-year life (EquityZen blog, “10 Facts for 10 Years of Funds”, 2025).

The commitment, the ROFR and the close

Once you reserve an allocation, sign the term sheet and wire, you are in. Trustpilot reviewers repeatedly note that the investor cannot back out once committed, although the fund can (Trustpilot, sampled September 2026; unverified customer reports). When enough commitments are in, the fund “closes” to new money and the company’s ROFR clock starts. EquityZen’s help center says a typical ROFR period is 30 days but depends on the company, and that the company can waive its right, let it expire, or buy the shares itself on the same terms. If EquityZen cannot close because the company exercises its ROFR, it says it will promptly return your principal and the sales fee (EquityZen help center, “Right of First Refusal (ROFR) clause”, retrieved September 2026). The stated timeline is that a transaction closes 8 to 11 weeks after the fund stops accepting commitments, and can run longer if a step extends (EquityZen help center, “How do I invest on EquityZen?”).

Some third-party reviewers describe EquityZen as a “ROFR-first” platform that clears the company’s right before a deal is listed (AltStreet, 2026; unverified at publication). EquityZen’s own help article describes something else, and the Trustpilot record includes investors who waited months and then lost the allocation to a ROFR (Trustpilot, sampled September 2026; unverified). Our reading is that EquityZen pre-checks transferability and the company’s process, which is real work, but the ROFR itself runs during the closing window on most Standard Deals. It publishes no closing rate.

Distributions and valuations

Between purchase and exit there is nothing to distribute. EquityZen reports a mark based on the last round or observed secondary prices; it is an unrealised figure and it is EquityZen’s. At an IPO the fund waits out the 180-day lockup, then either transfers your pro rata shares to a brokerage account you name or, if you elect it, sells them through a brokerage partner and wires the cash (EquityZen blog, “What happens when my pre-IPO investment goes public?”, retrieved September 2026). Restricted-stock rules can push the first sale to the later of the lockup expiry or one year after the fund bought the shares (same source).

Where EquityZen is paid

Four places. A 2.5% placement fee from the buyer at close, paid to EquityZen Securities. A 2.5% fee from the seller at close. A 2.5% fee from the seller of an Express Deal. And on managed funds, an annual management fee of 1.70% to 2.75%, 15% of profits, and about 1% a year of fund expenses (EquityZen help center, “How do I invest on EquityZen?” and “Investing in Growth Opportunity Fund XI LLC”, retrieved September 2026). Morgan Stanley is paid a fifth way that never shows on your statement: product and liquidity for its wealth clients and at-work participants, the reason it bought the company (Morgan Stanley press release, January 27, 2026).

This section lists what an accredited investor can actually buy on EquityZen as of September 17, 2026, with the terms as the platform states them, and what has changed since the sale.

Standard Deals (single-company funds)

The core product. One company, one block, one fund. Minimums typically run $10,000 to $20,000, with a limited number of $5,000 slots on certain deals allocated first come, first served by the time an investor completes the term sheet (EquityZen help center, “How do I invest on EquityZen?”, retrieved September 2026). Morgan Stanley confirmed on February 19, 2026 that “industry-lowest minimums of $5,000 will continue” (Morgan Stanley press release, February 19, 2026). Fee: 2.5% of the investment “for most transactions” (same release); the help center adds a lower 2% rate on very large tickets (unverified at publication). No management fee, carry or ongoing charge “typically”; the help center tells you to read the offering document for exceptions. EquityZen publishes no target return per deal.

The names on the board change weekly and depend entirely on who is selling. EquityZen’s own quarterly trends reports have put artificial intelligence at the top of investor demand through 2025 and the first half of 2026 (EquityZen blog, “Private Market Investment Trends”, Q3 2025 and Q2 2026). The three names every reader asks about need separate treatment:

• SpaceX is no longer a pre-IPO company. It listed on Nasdaq as SPCX on June 12, 2026 at $135 a share, raised about $75B, and closed its first day at $160.95 (CNBC; Nasdaq, June 12, 2026). Any EquityZen SpaceX fund is inside its lockup.
• OpenAI maintains a published policy that it does not endorse sales of its equity, SPV interests, tokens or forward contracts, that such transfers violate its restrictions, and that it may invalidate the underlying equity (OpenAI, “Unauthorized OpenAI Equity Transactions”, 2025; TechCrunch, August 23, 2025).
• Anthropic posted a notice on May 11, 2026 that transfers of its stock through eight named firms are void and that it does not permit SPVs to hold its stock; the list was Open Doors Partners, Unicorns Exchange, Pachamama Capital, Lionheart Ventures, Hiive and Forge Global (both for new offerings), Sydecar and Upmarket, and Forge and Hiive both disputed it (TechCrunch, May 12, 2026; Quartz, May 15, 2026). EquityZen was not on the list, which is consistent with closing only company-approved transfers and is not a promise that Anthropic blocks will appear.

The marquee AI names appear rarely and in small blocks, a listing is not an allocation, and the 49,000-transaction history is built on the long tail of 450 companies, not the three the headlines cover (Morgan Stanley press release, January 27, 2026; Forbes, May 26, 2026).

Express Deals (resales of fund units)

A secondary market in EquityZen’s own funds. To sell, you must have held the position for at least one year and the units offered must exceed 2% of the underlying fund; the seller pays 2.5% at close (EquityZen help center, “Express Deals”, retrieved September 2026). Buyers pay the Standard Deal fee. Because the company’s ROFR does not apply to a change in the fund’s membership, these close in days rather than months.

Managed funds (Growth Opportunity Fund XI and XII)

Diversified late-stage funds of 15 to 20 companies, chosen by an EquityZen investment committee. Minimum $50,000, with a limited number of $20,000 slots. Fees: annual management fee of 1.70% to 2.75% with breakpoints for commitment size and earlier closings, 15% carried interest on capital returned above committed capital (an 85/15 split), and an expected 1.0% a year of uncapped expenses for administration and tax (EquityZen help center, “Investing in Growth Opportunity Fund XI LLC”, retrieved September 2026). Fund lives run five to seven years and the series has run since 2015 (EquityZen blog, “10 Facts for 10 Years of Funds”, 2025). EquityZen publishes no net return for the managed funds. A third-party figure of 15% to 25% net IRR (ModernAlts, 2026) could not be traced to any EquityZen page or filing, and we do not use it.

What has closed or changed

Nothing on the menu was withdrawn at the acquisition. The change is price: both fees halved to 2.5% on February 19, 2026, and the cut was extended to Express Deals (Morgan Stanley press release; Reuters, February 19, 2026). The one service change customers describe is administrative, not contractual: Trustpilot reviewers in 2026 report that post-IPO distribution proceeds are handled through Morgan Stanley and that updates on those distributions have been slow (Trustpilot, sampled September 2026; unverified customer reports).

This section counts every dollar EquityZen or its funds take, then runs a $25,000 position through a three-year hold. The fee is the platform’s best feature since February 2026 and it is still large relative to the spread between a good and a bad private-market price.

The direct fees

• Buyer placement fee: 2.5% of the amount invested on a Standard Deal for most transactions; 2.5% up to $10M on a Direct Share Acquisition, 2% above. One time, at close, paid to EquityZen Securities LLC (EquityZen help center, retrieved September 2026; Morgan Stanley press release, February 19, 2026). Before February 19, 2026 the standard rate was 5% (Reuters; Bloomberg, February 19, 2026).
• Seller fee: 2.5% of proceeds at close, down from 5% (same sources). The seller pays it, but a rational seller prices it into the ask, so the buyer bears some share of it in the price.
• Express Deal seller fee: 2.5% (EquityZen help center, “Express Deals”).
• Managed fund fees: 1.70% to 2.75% a year on committed capital, 15% carry, about 1% a year of expenses, uncapped (EquityZen help center, “Investing in Growth Opportunity Fund XI LLC”).

The embedded and conditional costs

• Fund expenses on Standard Deals: EquityZen says single-company funds carry no ongoing fees and “typically” no carry or management fee. Every series still needs a tax return and a K-1; who pays is in the operating agreement, which we could not read. Ask before you wire.
• Post-IPO sale: if you ask the fund to sell your shares through its brokerage partner rather than take delivery, the partner’s commission applies; EquityZen does not publish it (EquityZen blog, “What happens when my pre-IPO investment goes public?”).
• Wires: your bank’s fee, typically $15 to $35, and again if the money comes back; EquityZen lists none of its own.
• Opportunity cost of a failed close: if the company exercises its ROFR at week ten, you have had $25,000 idle for ten weeks. At a 4% money-market yield that is about $190 forgone, before counting the deal you did not do instead.
• Price: the fee is 2.5%, but the price you pay is the seller’s, and the spread between EquityZen’s listing and the last institutional round can be far larger than 2.5% in either direction. The listed pre-IPO funds show what retail demand does to a price: in May 2026 RVI traded about 90% above its net asset value and DXYZ 151% above (CEFData; ValueAddVC; Morningstar, May 2026). On a 40% premium to the last round, the 2.5% fee is a rounding error and the premium is the cost.

A worked example: $25,000, three years, an IPO

Assume you take a $25,000 allocation in a Standard Deal on March 1, 2026. EquityZen publishes no target return, so we use a plain doubling: the company lists in year two, the lockup ends, and you take delivery of shares worth $50,000 on March 1, 2029. The arithmetic, each fee in turn:

1. Entry. You wire $25,000 plus the 2.5% placement fee of $625, total $25,625. (If a deal deducts the fee from the investment instead, you own 2.5% fewer units; EquityZen’s pages do not say which, so read the term sheet. The net return is the same to within a few dollars.)
2. Holding. No management fee, no carry, no expense charge on a Standard Deal per the help center. Three years of zero cash flow.
3. Exit. The fund distributes your pro rata shares after the 180-day lockup. You sell them in your own brokerage at $0 commission: $50,000 gross. No EquityZen exit fee applies to a distribution in kind.
4. Tax. Your basis is $25,625 (the fee is part of your cost). Gain of $24,375. The fund held the stock more than a year, so it is long-term capital gain at up to 20% plus the 3.8% net investment income tax: $5,801 at the top rate.
5. Net. $50,000 minus $5,801 is $44,199 on $25,625 out the door: a 72.5% net gain, about 19.9% a year compounded over three years.

Now the cases that are not a doubling. If the company exercises its ROFR at week ten, you get $25,625 back, principal and fee, per the help center, and have earned nothing for ten weeks. If the company lists flat and the shares are worth $25,000 on delivery, you are down the $625 fee, a 2.4% loss with no offsetting income. If the company is sold for half its last round, which happened to plenty of 2021-vintage names in 2023 and 2024, you receive $12,500 and a capital loss.

The liquid comparison: put the same $25,625 into a Nasdaq-100 ETF such as QQQ (expense ratio 0.18% since December 22, 2025, down from 0.20%; Invesco) and assume, as an assumption and not a forecast, 10% a year net of that fee. After three years the position is $34,107; the $8,482 gain is taxed at 23.8% for $32,088 net. EquityZen’s doubling case beats that by $12,111. Its flat case loses to it by $7,088, and its ROFR case loses to it by about $6,500 of forgone compounding, before you find another deal. The fee is not what decides this; the price you pay for the private shares is.

The managed funds, priced

A $50,000 commitment to Growth Opportunity Fund XI at a 2.25% management fee (the middle of the stated 1.70% to 2.75% band) and the expected 1.0% of expenses pays about $1,625 a year, or $9,750 over a six-year life, before any carry. If the fund returns 2× gross, the manager takes 15% of the $50,000 profit, $7,500, so the investor’s gross gain of $50,000 becomes $32,750 before tax, a 1.66× net multiple and about 8.8% a year over six years. That is a 3.25% annual drag plus a 15% profit share; the price of diversification here is most of the excess return a good vintage would deliver.

This section sets EquityZen’s own performance claims beside what can be seen to have happened. The short version: the headline number is large, undated, unaudited and dominated by the best years of the last decade; the individual realised exits are visible and mixed.

What EquityZen claims

EquityZen’s investment-returns page and its blog state that the platform has helped clients exit more than 100 company investments, including more than 60 IPOs, over an 11-year history, generating a net aggregate IRR of 43% for investors (EquityZen, investment-returns page and blog, retrieved September 2026). The page does not say the period the 43% covers, how funds that have not exited are treated, whether it is dollar-weighted across all investors or across exits only, or who calculated it. The same page warns investors not to place much reliance on annualised return calculations because timing and market risk can change the result dramatically, and it shows per-company annualised returns through June 30, 2021 that ranged from a 100% loss to a 2,831% gain (EquityZen investment-returns page, retrieved September 2026). An aggregate built from a distribution that wide is a mean, not an expectation. For the managed funds, EquityZen publishes no net return at all.

What has been realised

The visible record is by company. EquityZen’s own analysis of the 2025 IPO class (EquityZen blog, “Analyzing the Returns of the 2025 Tech IPO Class”, late 2025) reports for Klarna a return of +544% from its 2015 valuation to the IPO price, −3% on the IPO day, and −22.5% after listing, year to date at the time of writing. EquityZen’s stated conclusion is that the vast majority of wealth creation for the 2025 IPO class happened before those companies rang the opening bell, which is both a case for its product and an admission that a 2024 or 2025 buyer was late to most of the gain.

EquityZen counted 16 exits in 2025, naming Circle, CoreWeave and Klarna (EquityZen blog, “2025 Private Markets Year in Review”). It has not published the entry prices its funds paid for those names, so the realised return to an EquityZen investor, as distinct from the return from a 2015 round to the IPO, cannot be reconstructed from public sources. The Klarna figure is the clearest example: a fund formed in 2021 near Klarna’s peak round, reported at about $45.6B, would have been deeply underwater at a September 2025 IPO that priced at $40 a share and a valuation near $15B (unverified at publication); a fund formed in 2023 after the down round would have done well. The 43% aggregate hides both.

The gap and why

Three reasons the claimed number and a new investor’s likely experience diverge. First, vintage: the 60-plus IPOs span 2015 to 2025 and include the 2020 to 2021 window when almost anything listed at a premium; EquityZen’s own 2022 layoffs were a response to the other side of that cycle (Axios, October 31, 2022). Second, survivorship in the aggregate: an IRR “on exits” excludes the funds still holding companies that have neither listed nor died, and the 2021 vintage of those is where the write-downs sit. Third, entry price: the platform’s return is measured from what its funds paid, and its funds paid what an employee seller asked in a market that Forbes described in May 2026 as murky, fraud-prone and full of SPV buyers who may never own the shares directly (Forbes, May 26, 2026). None of this is unique to EquityZen. What is unique is that Morgan Stanley could, if it chose, publish an audited vintage table; as of September 2026 it has not.

This section sets out how you get out, how long it takes, and what happens if the platform itself fails. The realistic answer is that you get out when the company lists or is sold, and not before, unless you own a large enough slice of a fund to use the Express Deal market.

The lockup you sign up for

There is no redemption right. A Standard Deal fund exists to hold one stock until a liquidity event; EquityZen’s help center describes the exit methods as an IPO, an acquisition, or a sale of your fund interest to another investor (EquityZen help center, “What are the methods if I want to exit or cash out my investment?”, retrieved September 2026). The holding period is the company’s timetable, and the median late-stage company on the platform has been private for a decade.

The Express Deal market

This is the only secondary. Eligibility is narrow: one year held, and a stake of more than 2% of the underlying fund (EquityZen help center, “Express Deals”). With a typical series raising $100,000 to $480,000 (EDGAR Form Ds), 2% is $2,000 to $9,600, so most investors above the $10,000 minimum clear it; a $5,000-slot investor in a $400,000 fund does not. The seller pays 2.5%; the buyer pays the Standard Deal fee; the price is whatever a buyer will pay, and EquityZen publishes no Express Deal volume, spread or time-to-fill figure. We would plan on it as an exit of last resort at a discount, not as liquidity.

Realised time to exit

For a company that lists, the sequence is: IPO, 180-day lockup, distribution of shares to your brokerage, then your own sale. If the fund bought less than a year before the IPO, restricted-stock rules can extend the wait to a year from the fund’s purchase (EquityZen blog, “What happens when my pre-IPO investment goes public?”). Cash acquisitions add escrow and holdback periods that can run a year or more. In practice, count on seven to nine months from IPO to cash and three to seven years from purchase to IPO if the company is one of the roughly 60 out of 450 that got there.

If Morgan Stanley or EquityZen fails

The funds are separate Delaware series with their own operating agreements; the shares are registered in the fund’s name on the company’s cap table, not in EquityZen’s. A failure of the platform would leave the funds intact but without a manager, and the operating agreement governs who replaces it. Morgan Stanley’s ownership makes an EquityZen insolvency remote as of 2026. The more realistic risk is a parent’s discretion: Forge Global, five days before it was due to become trustee for Linqto’s 13,000 customers, withdrew on July 15, 2026 citing compliance concerns, and Linqto says the instruction came from Forge’s new owner, Schwab (Bloomberg Law, July 2026; Linqto press release, August 10, 2026). A bank can also fold a product it no longer wants; the Trustpilot reports of slower distributions after the handover are what a change of operator feels like from the investor’s side.

This section covers what you receive, how it is taxed and where the traps are. The structure is a partnership for tax purposes, so the forms and the timing are the partnership’s, not a broker’s.

What you get

Each EquityZen fund is a Delaware LLC taxed as a partnership. EquityZen’s guidance is that the fund issues a Schedule K-1 only in years with a taxable event, generally the year the underlying company exits by IPO, acquisition or liquidation (EquityZen blog, “A beginner’s guide to K-1s for private placement investors”; EquityZen help center, “How is my investment treated for tax purposes?”, retrieved September 2026; unverified at publication). In a quiet year you may receive nothing. After the fund distributes shares to your brokerage, your own broker issues the Form 1099-B when you sell.

Character of the gain

A cash exit inside the fund passes through as capital gain on the K-1; if the fund held the stock more than a year it is long-term under Section 1222, taxed at 0%, 15% or 20% under Section 1(h) plus the 3.8% net investment income tax under Section 1411 above the thresholds. The 28% collectibles rate under Section 1(h)(4) does not apply to stock. A distribution of shares in kind is generally not itself taxable; under Section 735(b) your holding period in the distributed shares includes the fund’s holding period, so shares the fund bought three years ago are long-term in your hands the day you receive them. Your basis in the units, and then in the shares, includes the 2.5% placement fee. (The Code references are general rules, not from an EquityZen document; confirm with your adviser.)

QSBS does not apply

The Section 1202 exclusion for qualified small business stock requires that the stock be acquired at original issuance from the company (Section 1202(c)(1)(B)); a secondary purchase from an employee fails that test regardless of the fund wrapper. Do not let a seller or a salesperson imply otherwise.

State filings, UBTI and IRAs

The fund is a Delaware entity; the gain is yours and is reported in your resident state. A multi-company managed fund holding companies in several states can add state K-1 schedules; the single-company funds generally do not. EquityZen accepts self-directed IRAs, principally through Alto (EquityZen help center; unverified at publication). Capital gain from an unleveraged stock position is not unrelated business taxable income under Sections 512 and 514, so a traditional or Roth IRA can hold a Standard Deal fund without a Form 990-T in the normal case; the custodian will need the fund’s annual valuation, which is EquityZen’s mark. The 2.5% fee and the custodian’s fees are paid from IRA assets.

Timing

Partnership K-1s arrive late; funds that wait for the company’s own tax information routinely issue in September, which means an extension in any year with an exit. Budget for it.

This section starts with the risk that ends the investor, then gives the dated record. For EquityZen the record is clean where it is visible; the risk is in what is not visible.

The risk that ends the investor

Three ways to lose all or most of it. The company fails or is sold below your price: the ordinary venture outcome, and the one the 43% aggregate averages away. The fund’s shares are not what you think: the Linqto case shows how a fund-of-one platform can collapse when title, custody and transfer approval were never properly done. Linqto filed for Chapter 11 in the Southern District of Texas on July 8, 2025 amid an SEC investigation, after its own probe found many customers never owned the securities they thought they did; a plan was confirmed on February 6, 2026 for more than 13,000 investors and roughly $500M of customer money, targeting about 95% of fair market value (Sullivan & Cromwell; Orrick, February 2026; Business Wire, February 6, 2026). EquityZen’s defences against that outcome are the Form D on every series, the FINRA-member broker-dealer, and the company-approval step; they are good defences, and they are still the platform’s own processes. The third is price: a secondary premium that the eventual IPO never ratifies, which is the Klarna 2021 story and is not a fraud, just a loss.

Regulatory record: EquityZen

We searched for SEC actions, FINRA disciplinary actions, state orders, class actions and arbitration awards against EquityZen Inc. and EquityZen Securities LLC and found none (searches run September 2026). The BrokerCheck record for CRD 281820 shows EquityZen Securities LLC registered with the SEC since May 11, 2016 and no disclosed events: no regulatory actions, criminal matters, civil judicial proceedings or financial matters (FINRA BrokerCheck, retrieved September 2026). Anthropic’s May 2026 list of eight unauthorised platforms did not include EquityZen (TechCrunch, May 12, 2026).

Regulatory record: the market EquityZen is in

The pre-IPO fund business drew regulators’ attention in 2026. On August 14, 2026 the SEC charged Andrew Spaventa and three entities he controlled (The Spaventa Group LLC, TSG Capital Advisors LLC and TSG Alpha Partners LLC) with fraud in the unregistered offering of 11 funds that purported to give retail investors pre-IPO shares: more than $74M raised from more than 800 mostly retail investors between December 2020 and June 2025, at prices on average about 46% above what Spaventa paid, while investors were told the upfront fee was zero or at most 12.5% (SEC press release 2026-75 and Litigation Release 26611, August 14, 2026; pending as of September 17, 2026). FINRA published an investor insight on August 18, 2026, “Know the Risks of Pre-IPO Funds and Potential Fraud”, on the chance the IPO never comes, the difficulty of valuing the units, the lack of an exit, and outright scams (FINRA, August 18, 2026). OpenAI’s 2025 policy and Anthropic’s May 2026 notice are the issuer side of the same story. None of this names EquityZen. All of it is the reason a Morgan Stanley-owned, broker-dealer-intermediated, company-approved process is worth a fee.

Complaint patterns

Trustpilot: 4 out of 5 from 431 reviews, 56% of them five-star, as retrieved in September 2026 (Trustpilot, equityzen.com). The recurring negatives across the pages we sampled, all unverified customer reports: allocations lost to a company’s ROFR after weeks or months of waiting with money committed; the investor being unable to withdraw once committed while the fund can cancel; wires whose receipt was not confirmed for several days; and, in 2026, slow communication about post-IPO distribution proceeds after the handover to Morgan Stanley. The recurring positives: a clear process, responsive support, and Express Deals that closed faster than expected. Better Business Bureau: we could not locate a BBB profile or complaint count for EquityZen (unverified at publication). Reddit and Blind: threads exist and repeat the ROFR theme; we found no thread alleging lost funds or missing shares.

Red flags to weigh

• No closing rate. EquityZen publishes 49,000 completed transactions and no denominator. The ROFR complaint pattern says the denominator is meaningfully larger.
• No audited performance. A 43% net IRR with no date range, on a business owned since January 2026 by a bank that audits everything else it sells.
• Conflicts. Morgan Stanley at Work administers equity plans for private companies; Morgan Stanley Wealth sells their shares to its clients through EquityZen; Morgan Stanley’s investment bank wants their IPO mandates. Every party to a transaction can be a Morgan Stanley client. The fee is disclosed; the information asymmetry is not.
• Marks. The value on your dashboard between purchase and exit is EquityZen’s estimate. It is unrealised and it is not independent.

This section is two lists. The reader who fits is narrower than the marketing suggests and wider than the sceptic assumes.

Who it is for

• An accredited investor with a specific late-stage company in mind, a view on its price against the last round, and $10,000 to $50,000 they can leave untouched for three to seven years.
• A Morgan Stanley Wealth or Morgan Stanley at Work client who is offered a company-approved block through the integration and can check the price against public secondary marks.
• An employee of a private company who wants to sell part of a vested position: the seller fee is 2.5% since February 19, 2026, the process is company-approved, and the buyer pool includes the largest retail wealth franchise in the country.
• An investor who has already bought on Forge or Hiive at a higher fee tier and wants a cheaper venue for the next $25,000 in a name both platforms list.

Who should skip it

• Anyone who is not accredited: the platform cannot sell to you, and the listed funds in the alternatives table are the legal route.
• Anyone who needs the money inside five years, or who would be upset by ten weeks of a wire sitting idle and then coming back.
• Anyone buying the AI headline names at any price: the Forbes May 2026 survey and Anthropic’s May 2026 notice describe a market where the marquee blocks are scarce, contested, and sometimes void.
• Anyone whose total liquid net worth is under about $500,000; a $10,000 minimum and a one-in-three failure assumption do not diversify at that size.
• Anyone who wants diversification rather than a single name: the managed funds’ 1.70% to 2.75% plus 15% carry plus 1% expenses is a venture-fund fee load on a fund that buys at secondary prices; a listed fund at about 2% with daily liquidity is a fairer trade for that reader, premium to NAV permitting.

This section puts EquityZen beside the five named competitors and the plain listed alternative, one row each, then says which reader goes where. All figures are as of the dates given and the fee columns are the platforms’ own ranges, with the maximum stated where there is one.

Which reader goes where. If you want a specific name at the lowest all-in fee and can wait, EquityZen’s 2.5% and $5,000 to $20,000 minimum is the cheapest credible ticket as of September 2026, provided you check the price against the last round. If you want to see a live bid-ask before you commit and can write $25,000, Hiive’s order book is the better price-discovery tool, cheaper on the way in at its 0% standard buyer tier and dearer at the 4.85% top of its schedule, with the reputational cost of Anthropic’s May 2026 notice. If you already bank at Schwab and can write $100,000, Forge is the same product inside your existing account, at a fee that is negotiable at size. Augment is the newest and least tested of the four; its pricing lives in each offering document. If you are not accredited, or you want to be able to sell tomorrow, the listed funds are the only legal route, and the number to watch is not the management fee but the premium to NAV: RVI’s round trip from about 90% to roughly none between May and July 2026, and DXYZ’s 151% premium in May 2026, are the price of liquidity in a wrapper that cannot create new shares (CEFData; ValueAddVC; Morningstar, 2026). A patient reader who simply wants technology exposure and dislikes all of the above buys the Nasdaq-100 and waits for the IPOs.

This section is the real sequence and the six things to read before wiring. The account takes minutes; the reading takes an evening and is where the money is saved.

The sequence

1. Create an account at equityzen.com; complete the investor profile and accredited-investor self-certification (Rule 506(b); no third-party letter required as of September 2026).
2. Browse the deal list. Each listing shows the company, the price per share, the implied valuation, the minimum and the closing timetable.
3. Reserve an allocation or submit a Bid. A reservation is a queue position; a bid is a binding offer if accepted.
4. Sign the term sheet and the fund’s subscription documents electronically. Read the operating agreement of the specific series before signing; it governs expenses, replacement of the manager and distributions.
5. Wire the investment plus the 2.5% fee (or as the term sheet directs) from a bank account in your name, or through your Alto IRA. Keep the wire confirmation; several reviewers report multi-day delays in receipt confirmation.
6. Wait. The fund closes, the company’s ROFR runs (typically 30 days), the transfer is approved or the company buys the block, and the transaction closes 8 to 11 weeks after the fund closed. You then receive confirmation of your units and EquityZen’s periodic mark.

The six things to read before wiring

1. The last priced round and its date on EquityZen’s company page, against the listing price. The spread is your real cost.
2. The ROFR language in the term sheet: whether the company has waived, whether the block has been pre-approved, and the mechanics of the refund of principal and fee if the company buys.
3. The series operating agreement: expenses, who pays for the K-1, what the manager can do without a vote, and what happens if the manager resigns.
4. The Form D on EDGAR for the series once filed: the amount raised, the investor count, and the commission line, which should read 2.5%.
5. The distribution policy: in-kind delivery to your brokerage after the lockup versus a sale through EquityZen’s partner, and the partner’s commission.
6. BrokerCheck for CRD 281820: the registration status and disclosures on EquityZen Securities LLC (none disclosed as of September 2026), and the Morgan Stanley Smith Barney LLC record it sits beside since January 2026.

EquityZen in September 2026 is the best-priced way for an accredited individual to buy a named late-stage private company in a legal, company-approved, broker-dealer-intermediated structure, and it is still a bad product for most people who will be shown it. Those two statements are not in tension. The 2.5% fee since February 19, 2026 is the lowest published flat rate among the marketplaces and half what the platform charged a year earlier; the $5,000 slots are real; the Form D trail and the FINRA membership are the safeguards that Linqto’s customers wish they had had; Morgan Stanley’s balance sheet makes an operator failure unlikely. Against that, the product is a single illiquid position bought at a price the seller set, in a market where listed pre-IPO funds traded 90% to 151% above their marks in May 2026, through a process that can return your money with nothing after ten weeks and that publishes no rate for how often it does. The performance claim is a single undated, unaudited number.

We rate it 3.5 out of 5. It would move to 4 if EquityZen published an audited vintage table for its single-company funds and a closing rate by quarter, and stated in each term sheet whether the company’s ROFR has been cleared before the investor commits. It would move to 3 if the 2.5% fee were quietly raised for non-Morgan Stanley clients, if the Express Deal market were closed, or if the distribution-communication complaints of 2026 became a pattern of delayed proceeds. It would fall further on any regulatory finding against EquityZen Securities, of which there is none on the record as of September 17, 2026.

What to watch, with dates. The Form D series count on EDGAR: Series 2294 was June 16, 2026; if the count is not past roughly 2,500 by mid-2027 the post-acquisition supply story has not delivered. EquityZen Securities LLC’s annual audited report for fiscal 2026, due in early 2027, for revenue against the halved fee. The BrokerCheck record for CRD 281820 for any change in registration status as Morgan Stanley consolidates entities. FINRA’s and the SEC’s 2026 attention to pre-IPO funds, which has so far named others. And the IPO calendar for OpenAI and Anthropic, the first test of how EquityZen’s funds, its lockup process and its post-IPO distributions perform at scale under the new owner. Nothing in this review is investment advice; it is research, dated September 17, 2026, and you should verify the figures that matter to you before you act.